Europe Amyloidosis Treatment Market Size & Outlook

The amyloidosis treatment market in Europe is expected to reach a projected revenue of US$ 4,066.6 million by 2028. A compound annual growth rate of 7.8% is expected of Europe amyloidosis treatment market from 2022 to 2028.
Revenue, 2021 (US$M)
$2,403.6
Forecast, 2028 (US$M)
$4,066.6
CAGR, 2022 - 2028
7.8%
Report Coverage
Europe

Europe amyloidosis treatment market highlights

  • The Europe amyloidosis treatment market generated a revenue of USD 2,403.6 million in 2021.
  • The market is expected to grow at a CAGR of 7.8% from 2022 to 2028.
  • In terms of segment, al was the largest revenue generating type in 2021.
  • ATTR is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, France is expected to register the highest CAGR from 2022 to 2028.


Europe data book summary

Market revenue in 2021USD 2,403.6 million
Market revenue in 2028USD 4,066.6 million
Growth rate7.8% (CAGR from 2021 to 2028)
Largest segmentAl
Fastest growing segmentATTR
Historical data covered2018 - 2020
Base year for estimation2021
Forecast period covered2022 - 2028
Quantitative unitsRevenue in USD million
Market segmentationAL, AA, ATTR
Key market players worldwidePfizer Inc, Ionis Pharmaceuticals Inc, Takeda Pharmaceutical Co Ltd, Johnson & Johnson, Alnylam Pharmaceuticals Inc


Other key industry trends

  • In terms of revenue, Europe region accounted for 24.7% of the global amyloidosis treatment market in 2021.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2028.
  • MEA is the fastest growing regional market and is projected to reach USD 495.9 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Amyloidosis Treatment Market Scope

Amyloidosis treatment market segmentation & scope
AL
AA
ATTR
Chemotherapy
Immunotherapy
Combination Therapy
Targeted Therapy
Supportive Therapy
Pipeline Therapy

Amyloidosis Treatment Market Companies

Name Profile # Employees HQ Website

Europe amyloidosis treatment market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to amyloidosis treatment market will help companies and investors design strategic landscapes.


Al was the largest segment with a revenue share of 67.21% in 2021. Horizon Databook has segmented the Europe amyloidosis treatment market based on al, aa, attr covering the revenue growth of each sub-segment from 2018 to 2028.


Reasons to subscribe to Europe amyloidosis treatment market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe amyloidosis treatment market databook

  • Our clientele includes a mix of amyloidosis treatment market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe amyloidosis treatment market , including forecasts for subscribers. This continent databook contains high-level insights into Europe amyloidosis treatment market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe amyloidosis treatment market size, by country, 2018-2028 (US$M)

Europe Amyloidosis Treatment Market Outlook Share, 2021 & 2028 (US$M)

Europe amyloidosis treatment market size, by country, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more